美股市場個股詳情
RCKT Rocket Pharmaceuticals
- 16.820
- -0.160-0.94%
收盤價 11/04 16:00 (美東)
- 16.820
- 0.0000.00%
盤後 16:37 (美東)
15.30億總市值-6072市盈率TTM
17.110最高價16.428最低價71.33萬股成交量16.650今開16.980昨收1202.36萬成交額1.01%換手率虧損市盈率(靜)9097.59萬總股本32.52552周最高3.98市淨率11.92億流通值15.97552周最低--股息TTM7088.95萬流通股67.480歷史最高--股息率TTM4.02%振幅7.565歷史最低16.856平均價1股每手
關於Rocket Pharmaceuticals公司
Rocket Pharmaceuticals Inc 是一家後期生物製藥公司。公司專注於開發罕見和毀滅性兒科疾病的基因療法。公司的渠道產品包括用於Danaon病的RP-A501、用於範可尼貧血的RP-L102、用於白細胞粘附的RP-L201、用於丙酮酸激酶缺乏症的RP-L301和用於嬰兒惡性骨質疏鬆症的RP-L401。
公司介紹
公司代碼RCKT
公司名稱Rocket Pharmaceuticals
上市日期2015/02/18
發行價格6.00
成立日期1999
CEODr. Gaurav Shah, M.D.
所屬市場納斯達克
員工數量268
年結日12-31
公司地址9 Cedarbrook Drive
城市Cranbury
省份新澤西
國家美國
郵編08512
電話1-609-659-8001
董事高管
- 姓名
- 職務
- 年薪
- Dr. Gaurav Shah, M.D.
- Director and Chief Executive Officer
- 801.36萬
- Dr. Kinnari Patel, M.B.A.,Pharm.D.
- President, Chief Operating Officer and Head of R&D
- 484.61萬
- Jonathan Schwartz, M.D.
- Chief Medical Officer and Chief Gene Therapy Officer
- 315.78萬
- Mayo Pujols
- Chief Technical Officer and Executive Vice President
- 437.77萬
- Aaron Ondrey
- Chief Financial Officer
- --
- Raj Prabhakar
- Chief Business Officer and Senior Vice President
- --
- Martin Wilson, J.D.
- Chief Corporate Officer, Senior Vice President, General Counsel and Chief Compliance Officer
- --
- Mark White
- General Manager, Commercial Affairs
- --
- John Militello, C.P.A.
- Vice President, Finance, Senior Controller, Treasurer and Principal Accounting Officer
- 152.76萬
- Dr. Roderick Wong, M.D.
- Chairman of the Board
- 41.00萬
- Dr. Mikael Dolsten, M.D.
- Director
- --
- David P. Southwell
- Independent Director
- 40.00萬
- Carsten Boess
- Independent Director
- 42.75萬
- Dr. Fady Ibraham Malik, M.D.,PhD
- Independent Director
- 40.00萬
- Dr. Naveen Yalamanchi, M.D.
- Independent Director
- 41.75萬
- Robert Keith Woods
- Independent Director
- 56.87萬
- Dr. Elisabeth Bjork, M.D.,PhD
- Independent Director
- 41.00萬
- Pedro P. Granadillo
- Independent Director
- 43.00萬
- Dr. Gotham Makker, M.D.
- Independent Director
- 40.00萬
分析
目標價預測
暫無數據
熱議
美股
綜合熱度
股票代碼
最新價
升跌幅
暫無數據